http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0155300-A2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_77d9bf55e6700374867763cc2c6acaff http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ebc9be8ea70c8c097606887d85df82d2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9324381b7c4d467a92f3be2552ac7952 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2e1da720e333f29921bd13180e4b73ed |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
filingDate | 2001-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd4dee1f316e60185a039348705fc6fa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81ee1c0972d21d5b111036294f8ff7d5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46f939ba7b240fd3d9fa546b9bf8e648 |
publicationDate | 2001-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | WO-0155300-A2 |
titleOfInvention | Nucleic acids, proteins, and antibodies |
abstract | The present invention relates to novel lung cancer related polynucleotides and the polypeptides encoded by these polynucleotides herein collectively known as 'lung cancer antigens', and the use of such lung cancer antigens for detecting disorders of the lung, particularly the presence of lung cancer and lung cancer metastases. More specifically, isolated lung cancer associated nucleic acid molecules are provided encoding novel lung cancer associated polypeptides. Novel lung cancer polypeptides and antibodies that bind to these polypeptides are provided. Also provided are vectors, host cells, and recombinant and synthetic methods for producing human lung cancer associated polynucleotides and/or polypeptides. The invention further relates to diagnostic and therapeutic methods useful for diagnosing, treating, preventing and/or prognosing disorders related to the lung, including lung cancer, and therapeutic methods for treating such disorders. The invention further relates to screening methods for identifying agonists and antagonists of polynucleotides and polypeptides of the invention. The present invention further relates to methods and/or compositions for inhibiting the production and function of the polypeptides of the present invention. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1163252-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7141417-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1163252-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0192488-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7049089-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1637601-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1637601-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7777005-B2 |
priorityDate | 2000-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 3260.